Bexion Pharmaceuticals, Inc. Appoints Dr. Catherine Pearce, DHSc, MBA, to Board of Directors

/PRNewswire/ -- Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a new generation of biologic therapy to treat solid tumor...

Related Keywords

Cincinnati ,Ohio ,United States ,Xavier University ,William Windham ,Scott Shively ,Catherine Pearce ,Joyce Laviscount ,Prnewswire Bexion Pharmaceuticals Inc ,Cincinnati Children Hospital Medical Center ,Company Board Of Directors ,Board Of Trustees Xavier University ,Astrazeneca ,Teva Pharmaceuticals ,Nova Southeastern University ,Bexion Pharmaceuticals Inc ,Doctorate Of Health Sciences Dhsc ,Solebury Strategic Communications ,Bexion Pharmaceuticals ,Health Sciences ,Nova Southeastern ,Cincinnati Children ,